Heidelberg Pharma AG (LON:0QW5)
4.630
-0.030 (-0.64%)
At close: Jul 4, 2025
Heidelberg Pharma AG Revenue
Heidelberg Pharma AG had revenue of 1.27M EUR in the quarter ending February 28, 2025, with 0.27% growth. This brings the company's revenue in the last twelve months to 6.85M, down -24.29% year-over-year. In the fiscal year ending November 30, 2024, Heidelberg Pharma AG had annual revenue of 6.85M, down -30.53%.
Revenue (ttm)
6.85M EUR
Revenue Growth
-24.29%
P/S Ratio
33.81
Revenue / Employee
65.26K EUR
Employees
105
Market Cap
191.56M GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Nov 30, 2024 | 6.85M | -3.01M | -30.53% |
Nov 30, 2023 | 9.86M | -8.66M | -46.75% |
Nov 30, 2022 | 18.51M | 16.48M | 810.30% |
Nov 30, 2021 | 2.03M | -6.63M | -76.53% |
Nov 30, 2020 | 8.67M | 1.17M | 15.63% |
Nov 30, 2019 | Pro | Pro | Pro |
Nov 30, 2018 | Pro | Pro | Pro |
Nov 30, 2017 | Pro | Pro | Pro |
Nov 30, 2016 | Pro | Pro | Pro |
Nov 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 42.56B |
HSBC Holdings | 44.89B |
Shell | 217.54B |
Unilever | 50.25B |
Rolls-Royce Holdings | 18.91B |
British American Tobacco p.l.c. | 25.87B |
Rio Tinto Group | 42.86B |
RELX PLC | 9.43B |